Jun 26, 2020
Developing the right tools to identify and fight antimicrobial resistance across Australia will use insights from the largest cohort study in the Southern Hemisphere. Analysis of data collected over the past 15 years through the Sax Institute’s 45 and Up Study is set...
Jun 16, 2020
OUTBREAK industry partner Microba is a Brisbane-based biotech company that specialises in analysing microbial genomics, specifically – gut bacteria. Dr Ken McGrath is Microba’s Technology Liaison Manager… Q: What is your role with OUTBREAK? My background is...
Jun 12, 2020
OUTBREAK’s expert team spans many sectors, including the hospital system. For UTS Professor of Nursing Marilyn Cruickshank, the battle against antimicrobial resistance (AMR) has taken her from the ward to the policy table… Q: Why did you get involved with OUTBREAK?...
Jun 11, 2020
Professor Mitch Byrne leads the social and behavioural team within OUTBREAK’s Ethical, Legal and Social Implications stream. The team’s focus is on developing and maintaining community acceptance and a social licence for OUTBREAK to operate. Q: Human behaviour is such...
Jun 10, 2020
Australian pharmacists are in the box seat to play a major role in the fight against antibiotic-resistant superbugs, according to Dr Lisa Pont who is leading the Prescribing and Health Outcomes stream for OUTBREAK. Research shows patients see their GP on average six...
May 13, 2020
OUTBREAK’s Chief Technology Officer, Ian Pridham, explains the process of developing a world-first AI system with many complexities and potential users… Q: What is your role in the OUTBREAK project? My role is to make sure that we build technology and...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok